A Case of Scedosporium aurantiacum Infection in the United States
Autor: | Masako Mizusawa, Marissa Totten, Sean X. Zhang |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Antifungal medicine.medical_specialty Antifungal Agents medicine.drug_class Veterinary (miscellaneous) 030106 microbiology Treatment outcome Applied Microbiology and Biotechnology Microbiology Scedosporium 030207 dermatology & venereal diseases 03 medical and health sciences Scedosporium aurantiacum 0302 clinical medicine Medical microbiology Medicine Humans Colonization business.industry United States Research studies business Agronomy and Crop Science Healthcare providers Invasive Fungal Infections |
Zdroj: | Mycopathologia. 186(1) |
ISSN: | 1573-0832 |
Popis: | Scedosporium aurantiacum is one of the emergent opportunistic fungal pathogens among immunocompromised hosts. Colonization of S. aurantiacum can also occur in patients with underlying lung diseases such as cystic fibrosis. S. aurantiacum is highly resistant to multiple antifungal agents, and management of the infected patients can be very challenging compared to those infected with other species of Scedosporium. Clinical cases have been geographically restricted mostly in Australia with a small number of cases identified in Europe and Japan. Although clinical isolates of S. aurantiacum from the USA have been included in several research studies, no clinical case of S. aurantiacum infection from the USA has been described. We report a case of S. aurantiacum infection acquired in the SA. Awareness of S. aurantiacum among healthcare providers and the species-level identification for Scedosporium are critically important for appropriate selection of antifungal agents and improvement of treatment outcomes. |
Databáze: | OpenAIRE |
Externí odkaz: |